Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 35 to 65

Effect of Songling Xuemaikang Capsules on mild hypertension

Official title: Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized, Multicenter, Double-blind, Placebo-controlled Trial

Run by Xiyuan Hospital of China Academy of Chinese Medical Sciences · NCT06093932 · Data updated 2026-11-12

This study tests whether Songling Xuemaikang Capsules can help people with mild high blood pressure improve their heart and blood vessel health compared to a lifestyle change or a placebo.

More Essential Hypertension trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages35 Years to 65 Years
SexAll
Enrollment100 (estimated)
SponsorXiyuan Hospital of China Academy of Chinese Medical Sciences
Academic / other
Locations5 sites (Beijing, Beijing Municipality and 4 other locations)
StatusRecruiting
StartedApril 7, 2024
Main results expectedDecember 2024
Study endsDecember 2027
Registry record updatedAugust 20, 2024
Trial IDNCT06093932 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 35-65 with grade 1 essential hypertension who are not regularly taking antihypertensive medications.

Probably not a fit

Patients with significant liver or kidney dysfunction, serious comorbidities, or those currently on antihypertensive medications may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the efficacy of Songling Xuemaikang Capsules (SLXMKC) in patients with grade 1 essential hypertension. It aims to assess the capsules' impact on vascular function and structure, as well as to explore the underlying mechanisms of their therapeutic effects. Participants will receive either the SLXMKC, a lifestyle intervention, or a placebo in a randomized controlled format. The study targets individuals aged 35-65 who have not been consistently taking antihypertensive medications.

Why it matters

Potential benefit: If successful, this study could provide a new treatment option for managing grade 1 hypertension.

How similar studies have gone: While the specific approach of using Songling Xuemaikang Capsules is novel, similar studies on herbal interventions for hypertension have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 35-65 years old, male or female;
* Grade 1 essential hypertension;
* Taking no antihypertensive drugs or taking antihypertensive drugs irregularly in the past ;
* Sign the informed consent;

Exclusion Criteria:

* Significant liver and kidney dysfunction, ALT and AST upper the twice of normal range, Scr≥2.0mg/dl, eGFR\<60ml/(min·1. 73m2);
* Gastrointestinal diseases, which may affect drug absorption;
* Be allergic to the clinical trial medicine;
* Pregnant or breastfeeding women, men who plan to give birth within half a year;
* Combined with other serious primary diseases or malignant tumors;
* Hyperlipidemia with or without taking lipid-lowering drugs;
* Combined with left ventricular hypertrophy, ABI \< 0.9, CIMT ≥ 0.9mm or atherosclerotic plaque;
* Hypertensive comorbidities (cerebrovascular disease, other cardiovascular diseases, renal disease, peripheral artery disease, retinopathy, diabetes);
* Other serious conditions in which is not fit for the study.

Where it's running

  • Xiyuan Hospital of China Academy of Chinese Medical Sciences
    Beijing, Beijing Municipality, China
    Recruiting
  • Suzhou Hosptial of Traditional Chinese Medicine
    Suzhou, Jiangsu, China
    Not yet recruiting
  • Affiliated Hospital of Shandong University of Traditional Chinese Medicine
    Jinan, Shandong, China
    Not yet recruiting
  • China Academy of Chinese Medical Sciences Xiyuan Hospital Jining Hospital
    Jining, Shandong, China
    Not yet recruiting
  • China Academy of Chinese Medical Sciences Xiyuan Hospital Shanxi Hospital
    Taiyuan, Shanxi, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.